Laura S. Graham

PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer

W. Oh, A. Armstrong, T. Dorff, 2021, Prostate Cancer and Prostatic Diseases.

Mismatch repair deficiency and clinical implications in prostate cancer

M. Schweizer, Laura S. Graham, 2022, The Prostate.

Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies

P. Nelson, C. Pritchard, A. Alva, 2020, PloS one.

Hypermutation, Mismatch Repair Deficiency, and Defining Predictors of Response to Checkpoint Blockade

C. Pritchard, M. Schweizer, Laura S. Graham, 2021, Clinical Cancer Research.

Metastatic Adenocarcinoma of the Epididymis: A Case Report and Brief Literature Review

L. True, M. Schweizer, Laura S. Graham, 2017, Clinical genitourinary cancer.

Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative neoadjuvant trial in high‐risk localized prostate cancer

P. Nelson, W. Ellis, L. True, 2021, The Prostate.

Clinical, pathologic, and molecular features of amphicrine prostate cancer

C. Pritchard, M. Schweizer, E. Yu, 2023, The Prostate.

Management of Advanced Prostate Cancer in the Precision Oncology Era

S. Cramer, C. Gillette, G. Yette, 2023, Cancers.

Management of Prostate Cancer in Older Adults.

Ravi B. Parikh, J. Lin, A. Morgans, 2023, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration.

A. Alva, V. Koshkin, R. Garje, 2024, Prostate cancer and prostatic diseases.